Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-01-24FDA Approved: PERSERIS — Supplemental Application (Indivior Inc.)
FDA approved a supplemental application for Perseris (risperidone) filed by Indivior Inc. Perseris is a long-acting injectable antipsychotic…
-
FDA approval · 2025-01-24FDA Approved: ARIPIPRAZOLE — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved a supplemental application for aripiprazole oral from Camber Pharmaceuticals, resulting in approval of this generic product's l…
-
FDA approval · 2025-01-24FDA Approved: ARIPIPRAZOLE — Supplemental Application (VistaPharm, LLC)
FDA approved a supplemental application for aripiprazole from VistaPharm, LLC, for a generic aripiprazole product.
-
FDA approval · 2025-01-23FDA Approved: INVEGA SUSTENNA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for INVEGA SUSTENNA (paliperidone palmitate) from Janssen Pharmaceuticals, Inc. The action updates o…
-
FDA approval · 2025-01-23FDA Approved: ARIPIPRAZOLE — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for Lannett's generic aripiprazole, authorizing a generic formulation of the antipsychotic.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-01-23FDA Approved: ARIPIPRAZOLE — Supplemental Application (Dr. Reddy's Laboratories Inc)
FDA approved a supplemental application to authorize a new orally disintegrating tablet formulation of aripiprazole from Dr. Reddy's Laborat…
-
FDA approval · 2025-01-23FDA Approved: RISPERIDONE — Supplemental Application (Amici Pharma, Inc.)
FDA approved a supplemental application for risperidone from Amici Pharma, Inc., updating the drug's labeling and/or indications. This actio…
-
FDA approval · 2025-01-23FDA Approved: ARIPIPRAZOLE — Supplemental Application (Advagen Pharma Ltd)
FDA approved Advagen Pharma Ltd's supplemental application for aripiprazole (ARIPIPRAZOLE) under ANDA216351.
-
FDA approval · 2025-01-22FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approves a supplemental application for Fluphenazine hydrochloride from Alembic Pharmaceuticals Limited.
-
FDA approval · 2025-01-22FDA Approved: ERZOFRI EXTENDED-RELEASE — Supplemental Application (Shandong Luye Pharmaceutical Co., Ltd.)
FDA approved a supplemental application for ERZOFRI EXTENDED-RELEASE (paliperidone palmitate) from Shandong Luye Pharmaceutical Co., Ltd.
-
FDA approval · 2025-01-22FDA Approved: HALOPERIDOL — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for Haloperidol lactate from Fresenius Kabi USA, LLC.
-
FDA approval · 2025-01-22FDA Approved: TRIFLUOPERAZINE HYDROCHLORIDE — Supplemental Application (Sandoz Inc.)
FDA approved a supplemental application for trifluoperazine hydrochloride by Sandoz Inc., authorizing its generic formulation.
-
FDA approval · 2025-01-22FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (Patriot Pharmaceuticals LLC)
The FDA approved a supplemental application for haloperidol decanoate from Patriot Pharmaceuticals LLC, a long-acting antipsychotic.
-
FDA approval · 2025-01-22FDA Approved: HALOPERIDOL — Supplemental Application (Innogenix, Inc.)
FDA approved a supplemental application for HALOPERIDOL submitted by Innogenix, Inc., marking an approved update to the product through a su…
-
FDA approval · 2025-01-22FDA Approved: ARISTADA INITIO — Supplemental Application (Alkermes, Inc.)
The FDA approved a supplemental application for ARISTADA INITIO, providing a loading-dose formulation of aripiprazole lauroxil for initiatin…
-
FDA approval · 2025-01-22FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
FDA approved a supplemental application for Fluphenazine hydrochloride by PAI Holdings (PAI Pharma), updating the status of this generic pro…
-
FDA approval · 2025-01-22FDA Approved: PERPHENAZINE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for PERPHENAZINE (perphenazine) submitted by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceutical…
-
FDA approval · 2025-01-22FDA Approved: RISPERIDONE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for risperidone from Sun Pharmaceutical Industries, Inc., indicating an update to labeling or indica…
-
FDA approval · 2025-01-22FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for Fluphenazine hydrochloride from Aurobindo Pharma Limited.
-
FDA approval · 2025-01-22FDA Approved: THIOTHIXENE — Supplemental Application (Amneal Pharmaceuticals NY LLC)
FDA approved a supplemental application for thiothixene from Amneal Pharmaceuticals NY LLC.
-
FDA approval · 2025-01-22FDA Approved: THIORIDAZINE HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for THIORIDAZINE HYDROCHLORIDE (thioridazine hydrochloride) submitted by Chartwell RX, LLC, upda…
-
FDA approval · 2025-01-22FDA Approved: VERSACLOZ — Supplemental Application (TruPharma LLC)
FDA approved a supplemental application for VERSACLOZ (clozapine) submitted by TruPharma LLC. The approval concerns changes under a suppleme…
-
FDA approval · 2025-01-22FDA Approved: FLUPHENAZINE DECANOATE — Supplemental Application (Eugia US LLC)
FDA approved a supplemental application for Fluphenazine Decanoate submitted by Eugia US LLC.
-
FDA approval · 2025-01-22FDA Approved: RISPERDAL CONSTA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for RISPERDAL CONSTA (risperidone) from Janssen Pharmaceuticals, Inc. The approval results in change…
-
FDA approval · 2025-01-22FDA Approved: PERPHENAZINE — Supplemental Application (Endo USA, Inc.)
The FDA approved a supplemental application for perphenazine from Endo USA, Inc.